E
Evofem Biosciences Inc
F:1AQ1
Evofem Biosciences Inc
F:1AQ1
Price:
0.1432
EUR
-2.59%
Market Closed
Market Cap:
€65.8m
Cash Flow Statement
Cash Flow Statement
Evofem Biosciences Inc
Evofem Biosciences Inc
Currency: USD
| Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(79)
|
70
|
47
|
53
|
51
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
(1)
|
(106)
|
(68)
|
(67)
|
(65)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
6
|
5
|
5
|
10
|
|
| Cash from Operating Activities |
(75)
N/A
|
(29)
+61%
|
(15)
+48%
|
(9)
+41%
|
(4)
+56%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+68%
|
(0)
+64%
|
(0)
+90%
|
(0)
-275%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
58
|
4
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
7
|
4
|
6
|
4
|
3
|
|
| Other |
(1)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
64
N/A
|
8
-88%
|
6
-23%
|
5
-20%
|
3
-36%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
(12)
N/A
|
(22)
-79%
|
(9)
+56%
|
(4)
+56%
|
(1)
+80%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(76)
N/A
|
(29)
+61%
|
(15)
+48%
|
(9)
+42%
|
(4)
+56%
|
|
Switch to:
Switch to:
See Also
Discover More
